250 related articles for article (PubMed ID: 24290398)
41. Antenatal magnesium sulphate to prevent cerebral palsy in very preterm infants.
Doyle L; Crowther C; Middleton P; Voysey M; Marret S; Rouse D
BJOG; 2011 Jun; 118(7):891-2; author reply 892-3. PubMed ID: 21564486
[No Abstract] [Full Text] [Related]
42. MgSO4 for CP prevention: too good to be true?
Macones GA
Am J Obstet Gynecol; 2009 Jun; 200(6):589. PubMed ID: 19482111
[No Abstract] [Full Text] [Related]
43. Feasibility of implementing magnesium sulphate for neuroprotection in a tertiary obstetric unit.
Ow LL; Kennedy A; McCarthy EA; Walker SP
Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):356-60. PubMed ID: 22515404
[TBL] [Abstract][Full Text] [Related]
44. The feasibility of a randomized clinical perinatal trial: maternal magnesium sulfate for the prevention of cerebral palsy.
Rouse DJ; Hauth JC; Nelson KG; Goldenberg RL
Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 1):701-5. PubMed ID: 8828437
[TBL] [Abstract][Full Text] [Related]
45. The information gap between the required and the actual accrued information size in the meta-analysis of antenatal magnesium sulphate to prevent cerebral palsy in preterm infants.
Wetterslev J; Imberger G
BJOG; 2011 Jun; 118(7):890; author reply 891. PubMed ID: 21564485
[No Abstract] [Full Text] [Related]
46. A report from #BlueJC: are we convinced antenatal magnesium sulphate can prevent cerebral palsy in preterm infants?
Berggren EK; Leung EY
BJOG; 2014 Apr; 121(5):647. PubMed ID: 24636319
[No Abstract] [Full Text] [Related]
47. Magnesium sulfate, cerebral palsy prevention, and medical protocols.
Repke JT
Obstet Gynecol; 2013 Feb; 121(2 Pt 1):227-228. PubMed ID: 23344268
[No Abstract] [Full Text] [Related]
48. [State of the use of magnesium sulfate for prevention of cerebral palsy in pre-term newborn in the Rouen's hospital].
Millochau JC; Marret S; Oden S; Verspyck E
Gynecol Obstet Fertil; 2016; 44(7-8):446-9. PubMed ID: 27426688
[TBL] [Abstract][Full Text] [Related]
49. Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection.
Obstet Gynecol; 2010 Mar; 115(3):669-671. PubMed ID: 20177305
[TBL] [Abstract][Full Text] [Related]
50. School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo.
Doyle LW; Anderson PJ; Haslam R; Lee KJ; Crowther C;
JAMA; 2014 Sep; 312(11):1105-13. PubMed ID: 25226476
[TBL] [Abstract][Full Text] [Related]
51. Magnesium sulfate for preterm neuroprotection.
Ananth CV; Vintzileos AM
JAMA; 2004 Feb; 291(8):940; author reply 941. PubMed ID: 14982907
[No Abstract] [Full Text] [Related]
52. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?
Nelson KB; Grether JK
Pediatrics; 1995 Feb; 95(2):263-9. PubMed ID: 7838646
[TBL] [Abstract][Full Text] [Related]
53. Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA)--study protocol.
Crowther CA; Middleton PF; Wilkinson D; Ashwood P; Haslam R;
BMC Pregnancy Childbirth; 2013 Apr; 13():91. PubMed ID: 23570677
[TBL] [Abstract][Full Text] [Related]
54. Association between use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
Mittendorf R; Pryde PG; Lee KS
Am J Obstet Gynecol; 2003 Aug; 189(2):613. PubMed ID: 14524362
[No Abstract] [Full Text] [Related]
55. Magnesium sulfate for neuroprotection: what do we do now?
Scott JR
Obstet Gynecol; 2009 Sep; 114(3):500-501. PubMed ID: 19701025
[No Abstract] [Full Text] [Related]
56. Antenatal magnesium sulfate: Neuro-protection for preterm infants.
Oddie S; Tuffnell DJ; McGuire W
Arch Dis Child Fetal Neonatal Ed; 2015 Nov; 100(6):F553-7. PubMed ID: 25896966
[TBL] [Abstract][Full Text] [Related]
57. Cerebral Palsy in Very Preterm Infants: A Nine-Year Prospective Study in a French Population-Based Tertiary Center.
Chollat C; Bertrand E; Petit-Ledo A; de Vansay C; Voisin C; Dabaj I; Gillibert A; Marret S;
J Pediatr; 2021 Oct; 237():183-189.e6. PubMed ID: 34144033
[TBL] [Abstract][Full Text] [Related]
58. Impact of dosing schedule on uptake of neuroprotective magnesium sulfate.
Cuff RD; Sullivan SA; Chang EY
J Matern Fetal Neonatal Med; 2020 Mar; 33(6):982-986. PubMed ID: 30122071
[No Abstract] [Full Text] [Related]
59. Epidemiology of cerebral palsy.
Blair E; Watson L
Semin Fetal Neonatal Med; 2006 Apr; 11(2):117-25. PubMed ID: 16338186
[TBL] [Abstract][Full Text] [Related]
60. Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial.
Wolf HT; Brok J; Henriksen TB; Greisen G; Salvig JD; Pryds O; Hedegaard M; Weber T; Hegaard HK; Pinborg A; Huusom LD;
BJOG; 2020 Sep; 127(10):1217-1225. PubMed ID: 32237024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
